文献速递创伤与烧伤重症综合管理与镇静镇痛

改良老年创伤评分提升院内死亡预测:基于净获益与决策曲线分析

Enhancing geriatric trauma mortality prediction: Modifying and assessing the Geriatric Trauma Outcome Score with net benefit and decision curve analysis.
PubMed 文献 · Acad Emerg Med · 2025-02-06
一句话结论在TQIP2017老年创伤患者中,改良GTOS含7项变量(0–19分),预测院内死亡的AUC 0.92优于原GTOS的0.84,净获益更高。

本研究利用TQIP 2017数据纳入67,222例≥65岁、在Level I创伤中心治疗的老年创伤患者,以院内死亡(5.6%)为终点,通过机器学习筛选变量改良GTOS,并采用校准、区分度、净获益(NB)和决策曲线分析(DCA)评估。改良GTOS包含初始气道干预(5分)、GCS≤13(5分)、24 h内输注浓缩红细胞(3分)、穿透伤(2分)、年龄≥75岁(2分)、既往合并症(1分)、躯干伤(1分),总分0–19分。改良GTOS的AUC 0.92 vs 原GTOS 0.84(p<0.0001),误分类误差4.9% vs 5.2%,Brier评分0.036 vs 0.042。DCA显示在广泛的临床偏好范围内,改良GTOS的净获益高于全部治疗、不治疗及基于原GTOS决策。

要点

  • 改良GTOS变量及权重:初始气道干预5分、GCS≤13 5分、24 h内输注浓缩红细胞3分、穿透伤2分、年龄≥75岁2分、既往合并症1分、躯干伤1分,总分0–19分。
  • 在67,222例≥65岁老年创伤患者中,改良GTOS预测院内死亡的AUC 0.92,显著高于原GTOS的0.84(p<0.0001)。
  • 改良GTOS误分类误差4.9% vs 原GTOS 5.2%,Brier评分0.036 vs 0.042。
  • DCA显示在广泛的临床偏好范围内,使用改良GTOS预测院内死亡的净获益高于全部治疗、不治疗及基于原GTOS决策。
  • 作者认为净获益与决策曲线分析是校准和区分度指标的有价值补充,可全面评估预测模型和决策策略的临床有用性。

适用人群与场景

  • 年龄≥65岁、在Level I创伤中心治疗的老年创伤患者,数据来自Trauma Quality Improvement Program(TQIP)2017。

诊断标准与关键阈值

  • 改良GTOS评分变量及权重:初始气道干预(5分)、Glasgow Coma Scale≤13(5分)、24 h内输注浓缩红细胞(3分)、穿透伤(2分)、年龄≥75岁(2分)、既往合并症(1分)、躯干伤(1分),总分范围0–19分。

研究设计与关键结果

  • 研究类型为利用TQIP 2017数据的预测模型改良与评估研究,纳入67,222例≥65岁老年创伤患者,院内死亡5.6%。
  • 改良GTOS预测院内死亡的AUC 0.92 vs 原GTOS 0.84(p<0.0001),误分类误差4.9% vs 5.2%,Brier评分0.036 vs 0.042。
  • DCA显示在广泛的临床偏好范围内,使用改良GTOS预测院内死亡的净获益高于全部治疗、不治疗及基于原GTOS决策。

证据类型、等级与局限

  • 证据类型:基于TQIP 2017数据的预测模型改良与评估研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为改良GTOS模型较原GTOS具有更优的预测能力和临床实用性。
  • 作者认为净获益与决策曲线分析是校准和区分度指标的有价值补充,可全面评估预测模型和决策策略的临床有用性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Calibration and discrimination indicators alone are insufficient for evaluating the clinical usefulness of prediction models, as they do not account for the cost of misclassification errors. This study aimed to modify the Geriatric Trauma Outcome Score (GTOS) and assess the clinical utility of the modified model using net benefit (NB) and decision curve analysis (DCA) for predicting in-hospital mortality.

METHODS: The Trauma Quality Improvement Program (TQIP) 2017 was used to identify geriatric trauma patients (≥ 65 years) treated at Level I trauma centers. The outcome of interest was in-hospital mortality. The GTOS was modified to include additional patient, injury, and treatment characteristics identified through machine learning methods, focusing on early risk stratification. Calibration and discrimination indicators, along with NB and DCA, were utilized for evaluation.

RESULTS: Of the 67,222 admitted geriatric trauma patients, 5.6% died in the hospital. The modified GTOS score included the following variables with associated weights: initial airway intervention (5), Glasgow Coma Scale ≤13 (5), packed red blood cell transfusion within 24 h (3), penetrating injury (2), age ≥ 75 years (2), preexisting comorbidity (1), and torso injury (1), with a total range from 0 to 19. The modified GTOS demonstrated a significantly higher area under the curve (0.92 vs. 0.84, p < 0.0001), lower misclassification error (4.9% vs. 5.2%), and lower Brier score (0.036 vs. 0.042) compared to the original GTOS. DCA showed that using the modified GTOS for predicting in-hospital mortality resulted in higher NB than treating all, treating none, and treating based on the original GTOS across a wide range of clinician preferences.

CONCLUSIONS: The modified GTOS model exhibited superior predictive ability and clinical utility compared to the original GTOS. NB and DCA offer valuable complementary methods to calibration and discrimination indicators, comprehensively evaluating the clinical usefulness of prediction models and decision strategies.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Acharya P, Garwe T, Vesely SK, et al. Enhancing geriatric trauma mortality prediction: Modifying and assessing the Geriatric Trauma Outcome Score with net benefit and decision curve analysis. Acad Emerg Med. 2025. PMID: 39912692. doi:10.1111/acem.15103

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。